PharmTech Drug Digest 11.20
News|Articles|March 5, 2015

BASF Shores Up Specialty Amines Supply

BASF is expanding its Verbund site in Ludwigshafen to include production capacity for about 20 specialty amines.

 

BASF will expand its production capacity at its Verbund site in Ludwigshafen, Germany. The expansion will include the production capacity for about 20 specialty amines by early 2017 with an investment of an undisclosed double-digit million-euro amount, according to the press release.

BASF currently makes approximately 200 different amines including alkyl-, alkanol-, and alkoxyalkylamines, heterocyclic and aromatic, and specialty amines. Last Spring, the company announced the expanded capacity for amines at Verbund and in Nanjing, China, with startup plans expected in 2015.

The investment aims to meet growing demand in Europe, said Stefan Blank, president of BASF Intermediates division, in a press release. In January 2015, BASF announced that it planned to invest up to $65 million USD to expand some of its facilities, including the Ludwigshafen, Germany site, for its Polyvinyl pyrrolidone capabilities.

Source: BASF


Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.